Kyle Womack, MD
Neurology · Saint Louis, MONPI 1922065796
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $623 of the $895 with a category attached, or 69.6%. Every reported general payment came from a single manufacturer, Janssen Research & Development, LLC. That places this record below the midpoint for neurology clinicians in MO, where the typical reported total is $933.
Across 7 payments — averaging $127.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$895
Across 85 payments — averaging $14,865 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$1.1M
- Biogen$171K
- Genentech, Inc.$28K
What the payments were for
- Travel & lodging$62370%
- Food & beverage$27230%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 7 | $895 |
How this compares
$895 in reported general payments places this provider in the 45th percentile of 381 neurology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rivastigmine | 116 | $15,855 |
| Memantine Hcl | 199 | $4,556 |
| Donepezil Hcl | 365 | $2,834 |
| Galantamine ErGalantamine Hbr | 24 | $2,036 |
| Quetiapine Fumarate | 38 | $1,003 |
| Armodafinil | 12 | $909 |
| Duloxetine Hcl | 54 | $760 |
| Mirtazapine | 23 | $448 |
| Escitalopram Oxalate | 59 | $438 |
| Sertraline Hcl | 66 | $406 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 11 | $117 |
| Trazodone Hcl | 23 | $82 |
| Lorazepam | 14 | $8 |
Paid to pharmacies, not to this prescriber.
Other neurology in Saint Louis
- Barry SingerSaint Louis$1.9M
- Mark TullmanSaint Louis$1.5M
- Robert NaismithSaint Louis$677K
- Arun VaradhacharySaint Louis$273K
- Anne CrossSaint Louis$190K
- David HoltzmanSaint Louis$165K
- Ghazala HayatSaint Louis$155K
- Pratap ChandSaint Louis$139K
- Lee TempelSaint Louis$121K
- Salim ChahinSaint Louis$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.